Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Newspaper reportRoche shareholders snub talk of Novartis merger
Basel, Switzerland-The Hoffmann and Oeri family heirs, who control a majority voting interest in Roche Holding AG although they own less than 10% of its equity, are reportedly not interested in merging the company with Novartis AG.
Related Videos
Related Content
